顶部logo
顶部logo
more_1

home

ホーム > レポート一覧 > ノミとダニの治療薬の世界市場規模、シェア、企業ランキング、売上、需要動向予測（2026～2032年）

ノミとダニの治療薬の世界市場規模、シェア、企業ランキング、売上、需要動向予測（2026～2032年）

Flea and Tick Medication- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
  • レポートID：
    294490
  • 発表時期：
    2026-05-13
  • レポート形式：
    PDF
  • 産業カテゴリー：
    消費財
  • レポート言語：
    英語、日本語
  • ページ数：
    145
  • 発行会社（調査会社）：
    QYResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。

※米ドル表示価格+10％消費税。

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界のノミとダニの治療薬市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点からノミとダニの治療薬市場を分析し、需要構造と成長特性を明確化します。
ノミとダニの治療薬市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、ノミとダニの治療薬に関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要ノミとダニの治療薬市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートはノミとダニの治療薬市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
ノミとダニの治療薬市場の主要企業には以下が含まれます：
Frontline
NexGard
Elanco
PetHonesty
Zoetis
Bravecto
Boehringer
Chewy
Capstar
Flea Away
Perrigo
Bayer Animal
Merck
Credelio
Hartz
Beaphar
Bayer
Virbac
Ceva
Sergeant's 

製品別
Liquid
Tablet 

アプリケーション別
Offline Sales
Online Sales 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
ノミとダニの治療薬市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
ノミとダニの治療薬市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別にノミとダニの治療薬市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別にノミとダニの治療薬市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、ノミとダニの治療薬市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、ノミとダニの治療薬市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
ノミとダニの治療薬市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
●ノミとダニの治療薬市場の全体像と成長見通し
ノミとダニの治療薬市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境がノミとダニの治療薬市場に与える影響を分析いたします。
●市場環境の構成要素とマクロトレンド
ノミとダニの治療薬産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します。
●競争構造と主要企業の動向分析
ノミとダニの治療薬市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します。
●競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点からノミとダニの治療薬市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします。
●成長要因・課題・リスクの分析
ノミとダニの治療薬市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します。
●将来トレンドと市場展望
ノミとダニの治療薬市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします。
title

Description

The global market for Flea and Tick Medication was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Flea and Tick Medication cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Flea and Tick Medication was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Flea and Tick Medication was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Flea and Tick Medication was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Flea and Tick Medication market include Frontline、NexGard、Elanco、PetHonesty、Zoetis、Bravecto、Boehringer、Chewy、Capstar、Flea Away, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Flea and Tick Medication, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Channel.

The Flea and Tick Medication market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Flea and Tick Medication.

Market Segmentation
By Company
    Frontline
    NexGard
    Elanco
    PetHonesty
    Zoetis
    Bravecto
    Boehringer
    Chewy
    Capstar
    Flea Away
    Perrigo
    Bayer Animal
    Merck
    Credelio
    Hartz
    Beaphar
    Bayer
    Virbac
    Ceva
    Sergeant's

Segment by Type
    Liquid
    Tablet

Segment by Channel
    Offline Sales
    Online Sales

Consumption by Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia-Pacific
    Europe
        Germany
        France
        U.K.
        Italy
        Netherlands
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Flea and Tick Medication manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Channel, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Flea and Tick Medication sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Flea and Tick Medication sales and revenue at the country level. It provides segmented data by Type and by Channel for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
title

Table of Contents

1 Market Overview
    1.1 Flea and Tick Medication Product Introduction
    1.2 Global Flea and Tick Medication Market Size Forecast
        1.2.1 Global Flea and Tick Medication Sales Value (2021–2032)
        1.2.2 Global Flea and Tick Medication Sales Volume (2021–2032)
        1.2.3 Global Flea and Tick Medication Sales Price (2021–2032)
    1.3 Flea and Tick Medication Market Trends & Drivers
        1.3.1 Flea and Tick Medication Industry Trends
        1.3.2 Flea and Tick Medication Market Drivers & Opportunities
        1.3.3 Flea and Tick Medication Market Challenges
        1.3.4 Flea and Tick Medication Market Restraints
        1.3.5 Impact of U.S. Tariffs
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global Flea and Tick Medication Players Revenue Ranking (2025)
    2.2 Global Flea and Tick Medication Revenue by Company (2021–2026)
    2.3 Global Flea and Tick Medication Sales Volume Ranking of Players (2025)
    2.4 Global Flea and Tick Medication Sales Volume by Company (2021–2026)
    2.5 Global Flea and Tick Medication Average Price by Company (2021–2026)
    2.6 Key Manufacturers Flea and Tick Medication Manufacturing Base and Headquarters
    2.7 Key Manufacturers Flea and Tick Medication Product Offerings
    2.8 Key Manufacturers Start of Mass Production of Flea and Tick Medication
    2.9 Flea and Tick Medication Market Competitive Analysis
        2.9.1 Flea and Tick Medication Market Concentration Rate (2021–2026)
        2.9.2 Global 5 and 10 Largest Manufacturers by Flea and Tick Medication Revenue in 2025
        2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Flea and Tick Medication revenue, 2025
    2.10 Mergers & Acquisitions and Expansion
3 Segmentation Flea and Tick Medication Market Classification
    3.1 Introduction by Type
        3.1.1 Liquid
        3.1.2 Tablet
        3.1.3 Global Flea and Tick Medication Sales Value by Type
            3.1.3.1 Global Flea and Tick Medication Sales Value by Type (2021 vs 2025 vs 2032)
            3.1.3.2 Global Flea and Tick Medication Sales Value, by Type (2021–2032)
            3.1.3.3 Global Flea and Tick Medication Sales Value, by Type (%), 2021–2032
        3.1.4 Global Flea and Tick Medication Sales Volume by Type
            3.1.4.1 Global Flea and Tick Medication Sales Volume by Type (2021 vs 2025 vs 2032)
            3.1.4.2 Global Flea and Tick Medication Sales Volume, by Type (2021–2032)
            3.1.4.3 Global Flea and Tick Medication Sales Volume, by Type (%), 2021–2032
        3.1.5 Global Flea and Tick Medication Average Price by Type (2021–2032)
4 Segmentation by Channel
    4.1 Introduction by Channel
        4.1.1 Offline Sales
        4.1.2 Online Sales
    4.2 Global Flea and Tick Medication Sales Value by Channel
        4.2.1 Global Flea and Tick Medication Sales Value by Channel (2021 vs 2025 vs 2032)
        4.2.2 Global Flea and Tick Medication Sales Value, by Channel (2021–2032)
        4.2.3 Global Flea and Tick Medication Sales Value, by Channel (%), 2021–2032
    4.3 Global Flea and Tick Medication Sales Volume by Channel
        4.3.1 Global Flea and Tick Medication Sales Volume by Channel (2021 vs 2025 vs 2032)
        4.3.2 Global Flea and Tick Medication Sales Volume, by Channel (2021–2032)
        4.3.3 Global Flea and Tick Medication Sales Volume, by Channel (%), 2021–2032
    4.4 Global Flea and Tick Medication Average Price by Channel (2021–2032)
5 Segmentation by Region
    5.1 Global Flea and Tick Medication Sales Value by Region
        5.1.1 Global Flea and Tick Medication Sales Value by Region: 2021 vs 2025 vs 2032
        5.1.2 Global Flea and Tick Medication Sales Value by Region (2021–2026)
        5.1.3 Global Flea and Tick Medication Sales Value by Region (2027–2032)
        5.1.4 Global Flea and Tick Medication Sales Value by Region (%), 2021–2032
    5.2 Global Flea and Tick Medication Sales Volume by Region
        5.2.1 Global Flea and Tick Medication Sales Volume by Region: 2021 vs 2025 vs 2032
        5.2.2 Global Flea and Tick Medication Sales Volume by Region (2021–2026)
        5.2.3 Global Flea and Tick Medication Sales Volume by Region (2027–2032)
        5.2.4 Global Flea and Tick Medication Sales Volume by Region (%), 2021–2032
    5.3 Global Flea and Tick Medication Average Price by Region (2021–2032)
    5.4 North America
        5.4.1 North America Flea and Tick Medication Sales Value, 2021–2032
        5.4.2 North America Flea and Tick Medication Sales Value by Country (%), 2025 vs 2032
    5.5 Europe
        5.5.1 Europe Flea and Tick Medication Sales Value, 2021–2032
        5.5.2 Europe Flea and Tick Medication Sales Value by Country (%), 2025 vs 2032
    5.6 Asia Pacific
        5.6.1 Asia Pacific Flea and Tick Medication Sales Value, 2021–2032
        5.6.2 Asia Pacific Flea and Tick Medication Sales Value by Region (%), 2025 vs 2032
    5.7 South America
        5.7.1 South America Flea and Tick Medication Sales Value, 2021–2032
        5.7.2 South America Flea and Tick Medication Sales Value by Country (%), 2025 vs 2032
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Flea and Tick Medication Sales Value, 2021–2032
        5.8.2 Middle East & Africa Flea and Tick Medication Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Flea and Tick Medication Sales Value Growth Trends, 2021 vs 2025 vs 2032
    6.2 Key Countries/Regions Flea and Tick Medication Sales Value and Sales Volume
        6.2.1 Key Countries/Regions Flea and Tick Medication Sales Value, 2021–2032
        6.2.2 Key Countries/Regions Flea and Tick Medication Sales Volume, 2021–2032
    6.3 United States
        6.3.1 United States Flea and Tick Medication Sales Value, 2021–2032
        6.3.2 United States Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
        6.3.3 United States Flea and Tick Medication Sales Value by Channel, 2025 vs 2032
    6.4 Europe
        6.4.1 Europe Flea and Tick Medication Sales Value, 2021–2032
        6.4.2 Europe Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
        6.4.3 Europe Flea and Tick Medication Sales Value by Channel, 2025 vs 2032
    6.5 China
        6.5.1 China Flea and Tick Medication Sales Value, 2021–2032
        6.5.2 China Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
        6.5.3 China Flea and Tick Medication Sales Value by Channel, 2025 vs 2032
    6.6 Japan
        6.6.1 Japan Flea and Tick Medication Sales Value, 2021–2032
        6.6.2 Japan Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
        6.6.3 Japan Flea and Tick Medication Sales Value by Channel, 2025 vs 2032
    6.7 South Korea
        6.7.1 South Korea Flea and Tick Medication Sales Value, 2021–2032
        6.7.2 South Korea Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
        6.7.3 South Korea Flea and Tick Medication Sales Value by Channel, 2025 vs 2032
    6.8 Southeast Asia
        6.8.1 Southeast Asia Flea and Tick Medication Sales Value, 2021–2032
        6.8.2 Southeast Asia Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
        6.8.3 Southeast Asia Flea and Tick Medication Sales Value by Channel, 2025 vs 2032
    6.9 India
        6.9.1 India Flea and Tick Medication Sales Value, 2021–2032
        6.9.2 India Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
        6.9.3 India Flea and Tick Medication Sales Value by Channel, 2025 vs 2032
7 Company Profiles
    7.1 Frontline
        7.1.1 Frontline Company Information
        7.1.2 Frontline Introduction and Business Overview
        7.1.3 Frontline Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.1.4 Frontline Flea and Tick Medication Product Offerings
        7.1.5 Frontline Recent Developments
    7.2 NexGard
        7.2.1 NexGard Company Information
        7.2.2 NexGard Introduction and Business Overview
        7.2.3 NexGard Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.2.4 NexGard Flea and Tick Medication Product Offerings
        7.2.5 NexGard Recent Developments
    7.3 Elanco
        7.3.1 Elanco Company Information
        7.3.2 Elanco Introduction and Business Overview
        7.3.3 Elanco Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.3.4 Elanco Flea and Tick Medication Product Offerings
        7.3.5 Elanco Recent Developments
    7.4 PetHonesty
        7.4.1 PetHonesty Company Information
        7.4.2 PetHonesty Introduction and Business Overview
        7.4.3 PetHonesty Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.4.4 PetHonesty Flea and Tick Medication Product Offerings
        7.4.5 PetHonesty Recent Developments
    7.5 Zoetis
        7.5.1 Zoetis Company Information
        7.5.2 Zoetis Introduction and Business Overview
        7.5.3 Zoetis Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.5.4 Zoetis Flea and Tick Medication Product Offerings
        7.5.5 Zoetis Recent Developments
    7.6 Bravecto
        7.6.1 Bravecto Company Information
        7.6.2 Bravecto Introduction and Business Overview
        7.6.3 Bravecto Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.6.4 Bravecto Flea and Tick Medication Product Offerings
        7.6.5 Bravecto Recent Developments
    7.7 Boehringer
        7.7.1 Boehringer Company Information
        7.7.2 Boehringer Introduction and Business Overview
        7.7.3 Boehringer Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.7.4 Boehringer Flea and Tick Medication Product Offerings
        7.7.5 Boehringer Recent Developments
    7.8 Chewy
        7.8.1 Chewy Company Information
        7.8.2 Chewy Introduction and Business Overview
        7.8.3 Chewy Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.8.4 Chewy Flea and Tick Medication Product Offerings
        7.8.5 Chewy Recent Developments
    7.9 Capstar
        7.9.1 Capstar Company Information
        7.9.2 Capstar Introduction and Business Overview
        7.9.3 Capstar Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.9.4 Capstar Flea and Tick Medication Product Offerings
        7.9.5 Capstar Recent Developments
    7.10 Flea Away
        7.10.1 Flea Away Company Information
        7.10.2 Flea Away Introduction and Business Overview
        7.10.3 Flea Away Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.10.4 Flea Away Flea and Tick Medication Product Offerings
        7.10.5 Flea Away Recent Developments
    7.11 Perrigo
        7.11.1 Perrigo Company Information
        7.11.2 Perrigo Introduction and Business Overview
        7.11.3 Perrigo Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.11.4 Perrigo Flea and Tick Medication Product Offerings
        7.11.5 Perrigo Recent Developments
    7.12 Bayer Animal
        7.12.1 Bayer Animal Company Information
        7.12.2 Bayer Animal Introduction and Business Overview
        7.12.3 Bayer Animal Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.12.4 Bayer Animal Flea and Tick Medication Product Offerings
        7.12.5 Bayer Animal Recent Developments
    7.13 Merck
        7.13.1 Merck Company Information
        7.13.2 Merck Introduction and Business Overview
        7.13.3 Merck Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.13.4 Merck Flea and Tick Medication Product Offerings
        7.13.5 Merck Recent Developments
    7.14 Credelio
        7.14.1 Credelio Company Information
        7.14.2 Credelio Introduction and Business Overview
        7.14.3 Credelio Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.14.4 Credelio Flea and Tick Medication Product Offerings
        7.14.5 Credelio Recent Developments
    7.15 Hartz
        7.15.1 Hartz Company Information
        7.15.2 Hartz Introduction and Business Overview
        7.15.3 Hartz Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.15.4 Hartz Flea and Tick Medication Product Offerings
        7.15.5 Hartz Recent Developments
    7.16 Beaphar
        7.16.1 Beaphar Company Information
        7.16.2 Beaphar Introduction and Business Overview
        7.16.3 Beaphar Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.16.4 Beaphar Flea and Tick Medication Product Offerings
        7.16.5 Beaphar Recent Developments
    7.17 Bayer
        7.17.1 Bayer Company Information
        7.17.2 Bayer Introduction and Business Overview
        7.17.3 Bayer Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.17.4 Bayer Flea and Tick Medication Product Offerings
        7.17.5 Bayer Recent Developments
    7.18 Virbac
        7.18.1 Virbac Company Information
        7.18.2 Virbac Introduction and Business Overview
        7.18.3 Virbac Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.18.4 Virbac Flea and Tick Medication Product Offerings
        7.18.5 Virbac Recent Developments
    7.19 Ceva
        7.19.1 Ceva Company Information
        7.19.2 Ceva Introduction and Business Overview
        7.19.3 Ceva Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.19.4 Ceva Flea and Tick Medication Product Offerings
        7.19.5 Ceva Recent Developments
    7.20 Sergeant's
        7.20.1 Sergeant's Company Information
        7.20.2 Sergeant's Introduction and Business Overview
        7.20.3 Sergeant's Flea and Tick Medication Sales, Revenue, Price and Gross Margin (2021–2026)
        7.20.4 Sergeant's Flea and Tick Medication Product Offerings
        7.20.5 Sergeant's Recent Developments
8 Industry Chain Analysis
    8.1 Flea and Tick Medication Industrial Chain
    8.2 Flea and Tick Medication Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Key Suppliers of Raw Materials
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customer Analysis)
    8.5 Sales Model and Sales Channelss
        8.5.1 Flea and Tick Medication Sales Model
        8.5.2 Sales Channels
        8.5.3 Flea and Tick Medication Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Flea and Tick Medication Market Trends
 Table 2. Flea and Tick Medication Market Drivers & Opportunities
 Table 3. Flea and Tick Medication Market Challenges
 Table 4. Flea and Tick Medication Market Restraints
 Table 5. Global Flea and Tick Medication Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Flea and Tick Medication Revenue Market Share by Company (2021–2026)
 Table 7. Global Flea and Tick Medication Sales Volume by Company (K Units), 2021–2026
 Table 8. Global Flea and Tick Medication Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Flea and Tick Medication Price by Company (US$/Unit), 2021–2026
 Table 10. Key Manufacturers Flea and Tick Medication Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Flea and Tick Medication Product Type
 Table 12. Key Manufacturers Start of Mass Production of Flea and Tick Medication
 Table 13. Global Flea and Tick Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Flea and Tick Medication revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Flea and Tick Medication Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Flea and Tick Medication Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Flea and Tick Medication Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Flea and Tick Medication Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Flea and Tick Medication Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Flea and Tick Medication Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
 Table 22. Global Flea and Tick Medication Sales Volume by Type (K Units), 2021–2026
 Table 23. Global Flea and Tick Medication Sales Volume by Type (K Units), 2027–2032
 Table 24. Global Flea and Tick Medication Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Flea and Tick Medication Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Flea and Tick Medication Price by Type (US$/Unit), 2021–2026
 Table 27. Global Flea and Tick Medication Price by Type (US$/Unit), 2027–2032
 Table 28. Global Flea and Tick Medication Sales Value by Channel: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Flea and Tick Medication Sales Value by Channel (US$ Million), 2021–2026
 Table 30. Global Flea and Tick Medication Sales Value by Channel (US$ Million), 2027–2032
 Table 31. Global Flea and Tick Medication Sales Market Share in Value by Channel (2021–2026)
 Table 32. Global Flea and Tick Medication Sales Market Share in Value by Channel (2027–2032)
 Table 33. Global Flea and Tick Medication Sales Volume by Channel: 2021 vs 2025 vs 2032 (K Units)
 Table 34. Global Flea and Tick Medication Sales Volume by Channel (K Units), 2021–2026
 Table 35. Global Flea and Tick Medication Sales Volume by Channel (K Units), 2027–2032
 Table 36. Global Flea and Tick Medication Sales Market Share in Volume by Channel (2021–2026)
 Table 37. Global Flea and Tick Medication Sales Market Share in Volume by Channel (2027–2032)
 Table 38. Global Flea and Tick Medication Price by Channel (US$/Unit), 2021–2026
 Table 39. Global Flea and Tick Medication Price by Channel (US$/Unit), 2027–2032
 Table 40. Global Flea and Tick Medication Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Flea and Tick Medication Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Flea and Tick Medication Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Flea and Tick Medication Sales Value by Region (%), 2021–2026
 Table 44. Global Flea and Tick Medication Sales Value by Region (%), 2027–2032
 Table 45. Global Flea and Tick Medication Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
 Table 46. Global Flea and Tick Medication Sales Volume by Region (K Units), 2021–2026
 Table 47. Global Flea and Tick Medication Sales Volume by Region (K Units), 2027–2032
 Table 48. Global Flea and Tick Medication Sales Volume by Region (%), 2021–2026
 Table 49. Global Flea and Tick Medication Sales Volume by Region (%), 2027–2032
 Table 50. Global Flea and Tick Medication Average Price by Region (US$/Unit), 2021–2026
 Table 51. Global Flea and Tick Medication Average Price by Region (US$/Unit), 2027–2032
 Table 52. Key Countries/Regions Flea and Tick Medication Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Flea and Tick Medication Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Flea and Tick Medication Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Flea and Tick Medication Sales Volume, (K Units), 2021–2026
 Table 56. Key Countries/Regions Flea and Tick Medication Sales Volume, (K Units), 2027–2032
 Table 57. Frontline Company Information
 Table 58. Frontline Introduction and Business Overview
 Table 59. Frontline Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 60. Frontline Flea and Tick Medication Product Offerings
 Table 61. Frontline Recent Developments
 Table 62. NexGard Company Information
 Table 63. NexGard Introduction and Business Overview
 Table 64. NexGard Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 65. NexGard Flea and Tick Medication Product Offerings
 Table 66. NexGard Recent Developments
 Table 67. Elanco Company Information
 Table 68. Elanco Introduction and Business Overview
 Table 69. Elanco Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 70. Elanco Flea and Tick Medication Product Offerings
 Table 71. Elanco Recent Developments
 Table 72. PetHonesty Company Information
 Table 73. PetHonesty Introduction and Business Overview
 Table 74. PetHonesty Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 75. PetHonesty Flea and Tick Medication Product Offerings
 Table 76. PetHonesty Recent Developments
 Table 77. Zoetis Company Information
 Table 78. Zoetis Introduction and Business Overview
 Table 79. Zoetis Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 80. Zoetis Flea and Tick Medication Product Offerings
 Table 81. Zoetis Recent Developments
 Table 82. Bravecto Company Information
 Table 83. Bravecto Introduction and Business Overview
 Table 84. Bravecto Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 85. Bravecto Flea and Tick Medication Product Offerings
 Table 86. Bravecto Recent Developments
 Table 87. Boehringer Company Information
 Table 88. Boehringer Introduction and Business Overview
 Table 89. Boehringer Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 90. Boehringer Flea and Tick Medication Product Offerings
 Table 91. Boehringer Recent Developments
 Table 92. Chewy Company Information
 Table 93. Chewy Introduction and Business Overview
 Table 94. Chewy Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 95. Chewy Flea and Tick Medication Product Offerings
 Table 96. Chewy Recent Developments
 Table 97. Capstar Company Information
 Table 98. Capstar Introduction and Business Overview
 Table 99. Capstar Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 100. Capstar Flea and Tick Medication Product Offerings
 Table 101. Capstar Recent Developments
 Table 102. Flea Away Company Information
 Table 103. Flea Away Introduction and Business Overview
 Table 104. Flea Away Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 105. Flea Away Flea and Tick Medication Product Offerings
 Table 106. Flea Away Recent Developments
 Table 107. Perrigo Company Information
 Table 108. Perrigo Introduction and Business Overview
 Table 109. Perrigo Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 110. Perrigo Flea and Tick Medication Product Offerings
 Table 111. Perrigo Recent Developments
 Table 112. Bayer Animal Company Information
 Table 113. Bayer Animal Introduction and Business Overview
 Table 114. Bayer Animal Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 115. Bayer Animal Flea and Tick Medication Product Offerings
 Table 116. Bayer Animal Recent Developments
 Table 117. Merck Company Information
 Table 118. Merck Introduction and Business Overview
 Table 119. Merck Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 120. Merck Flea and Tick Medication Product Offerings
 Table 121. Merck Recent Developments
 Table 122. Credelio Company Information
 Table 123. Credelio Introduction and Business Overview
 Table 124. Credelio Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 125. Credelio Flea and Tick Medication Product Offerings
 Table 126. Credelio Recent Developments
 Table 127. Hartz Company Information
 Table 128. Hartz Introduction and Business Overview
 Table 129. Hartz Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 130. Hartz Flea and Tick Medication Product Offerings
 Table 131. Hartz Recent Developments
 Table 132. Beaphar Company Information
 Table 133. Beaphar Introduction and Business Overview
 Table 134. Beaphar Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 135. Beaphar Flea and Tick Medication Product Offerings
 Table 136. Beaphar Recent Developments
 Table 137. Bayer Company Information
 Table 138. Bayer Introduction and Business Overview
 Table 139. Bayer Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 140. Bayer Flea and Tick Medication Product Offerings
 Table 141. Bayer Recent Developments
 Table 142. Virbac Company Information
 Table 143. Virbac Introduction and Business Overview
 Table 144. Virbac Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 145. Virbac Flea and Tick Medication Product Offerings
 Table 146. Virbac Recent Developments
 Table 147. Ceva Company Information
 Table 148. Ceva Introduction and Business Overview
 Table 149. Ceva Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 150. Ceva Flea and Tick Medication Product Offerings
 Table 151. Ceva Recent Developments
 Table 152. Sergeant's Company Information
 Table 153. Sergeant's Introduction and Business Overview
 Table 154. Sergeant's Flea and Tick Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
 Table 155. Sergeant's Flea and Tick Medication Product Offerings
 Table 156. Sergeant's Recent Developments
 Table 157. Key Raw Materials Lists
 Table 158. Key Suppliers of Raw Materials Lists
 Table 159. Flea and Tick Medication Downstream Customers
 Table 160. Flea and Tick Medication Distributors List
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources


List of Figures
 Figure 1. Flea and Tick Medication Product Picture
 Figure 2. Global Flea and Tick Medication Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 4. Global Flea and Tick Medication Sales Volume (K Units), 2021–2032
 Figure 5. Global Flea and Tick Medication Sales Price (US$/Unit), 2021–2032
 Figure 6. Flea and Tick Medication Report Years Considered
 Figure 7. Global Flea and Tick Medication Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Flea and Tick Medication Sales Volume Ranking of Players (K Units), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Flea and Tick Medication Revenue in 2025
 Figure 10. Flea and Tick Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Liquid Picture
 Figure 12. Tablet Picture
 Figure 13. Global Flea and Tick Medication Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Flea and Tick Medication Sales Value Market Share by Type, 2025 & 2032
 Figure 15. Global Flea and Tick Medication Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
 Figure 16. Global Flea and Tick Medication Sales Volume Market Share by Type, 2025 & 2032
 Figure 17. Global Flea and Tick Medication Price by Type (US$/Unit), 2021–2032
 Figure 18. Product Picture of Offline Sales
 Figure 19. Product Picture of Online Sales
 Figure 20. Global Flea and Tick Medication Sales Value by Channel (US$ Million), 2021 vs 2025 vs 2032
 Figure 21. Global Flea and Tick Medication Sales Value Market Share by Channel, 2025 & 2032
 Figure 22. Global Flea and Tick Medication Sales Volume by Channel (K Units), 2021 vs 2025 vs 2032
 Figure 23. Global Flea and Tick Medication Sales Volume Market Share by Channel, 2025 & 2032
 Figure 24. Global Flea and Tick Medication Price by Channel (US$/Unit), 2021–2032
 Figure 25. North America Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 26. North America Flea and Tick Medication Sales Value by Country (%), 2025 vs 2032
 Figure 27. Europe Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 28. Europe Flea and Tick Medication Sales Value by Country (%), 2025 vs 2032
 Figure 29. Asia Pacific Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 30. Asia Pacific Flea and Tick Medication Sales Value by Region (%), 2025 vs 2032
 Figure 31. South America Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 32. South America Flea and Tick Medication Sales Value by Country (%), 2025 vs 2032
 Figure 33. Middle East & Africa Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 34. Middle East & Africa Flea and Tick Medication Sales Value by Country (%), 2025 vs 2032
 Figure 35. Key Countries/Regions Flea and Tick Medication Sales Value (%), 2021–2032
 Figure 36. Key Countries/Regions Flea and Tick Medication Sales Volume (%), 2021–2032
 Figure 37. United States Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 38. United States Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
 Figure 39. United States Flea and Tick Medication Sales Value by Channel (%), 2025 vs 2032
 Figure 40. Europe Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 41. Europe Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
 Figure 42. Europe Flea and Tick Medication Sales Value by Channel (%), 2025 vs 2032
 Figure 43. China Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 44. China Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
 Figure 45. China Flea and Tick Medication Sales Value by Channel (%), 2025 vs 2032
 Figure 46. Japan Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 47. Japan Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
 Figure 48. Japan Flea and Tick Medication Sales Value by Channel (%), 2025 vs 2032
 Figure 49. South Korea Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 50. South Korea Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
 Figure 51. South Korea Flea and Tick Medication Sales Value by Channel (%), 2025 vs 2032
 Figure 52. Southeast Asia Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 53. Southeast Asia Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
 Figure 54. Southeast Asia Flea and Tick Medication Sales Value by Channel (%), 2025 vs 2032
 Figure 55. India Flea and Tick Medication Sales Value (US$ Million), 2021–2032
 Figure 56. India Flea and Tick Medication Sales Value by Type (%), 2025 vs 2032
 Figure 57. India Flea and Tick Medication Sales Value by Channel (%), 2025 vs 2032
 Figure 58. Flea and Tick Medication Industrial Chain
 Figure 59. Flea and Tick Medication Manufacturing Cost Structure
 Figure 60. Channels of Distribution (Direct Sales, and Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット
  • jiantou

    多言語（英語、日本語）のサンプル提供

  • jiantou

    プロフェッショナルな日本語翻訳を提供

  • jiantou

    請求書、クレジットカードでのお支払いが可能です

  • jiantou

    必要なチャプターやカスタマイズされたレポートの注文が可能

  • jiantou

    購入後、アナリストに直接連絡することができます

購入方法
shunxu

  • 必要な言語とバージョンのレポート選択

  • レポート要件と見積もり依頼

  • 電子メールによる注文

  • レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）

  • クレジットカード決済、オフライン振込に対応（後払い可）

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）
ご利用ガイド
利用規約よくあるご質問プライバシーポリシー支払い方法と購入ガイド
お電話でのお問い合わせ
email050-5840-2692 日本
email0081-50-5840-2692 グローバル
9:00-18:00 (土日・祝日を除く)
底部logo
Copyright 2016-2026 Global Reports著作権所有